These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24700747)

  • 1. A comprehensive review on controls in molecular imaging: lessons from MMP-2 imaging.
    Lebel R; Lepage M
    Contrast Media Mol Imaging; 2014; 9(3):187-210. PubMed ID: 24700747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of H-aggregation on activatable MMP-2-specific probes for optical imaging.
    Lebel R; Bonin MA; Zriba R; Radulska A; Neugebauer W; Lepage M
    Contrast Media Mol Imaging; 2012; 7(3):328-37. PubMed ID: 22539403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of MMP activity in postischemic cardiac remodeling using radiolabeled MMP-2/9 activatable peptide probes.
    van Duijnhoven SM; Robillard MS; Hermann S; Kuhlmann MT; Schäfers M; Nicolay K; Grüll H
    Mol Pharm; 2014 May; 11(5):1415-23. PubMed ID: 24641497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs).
    Rangasamy L; Geronimo BD; Ortín I; Coderch C; Zapico JM; Ramos A; de Pascual-Teresa B
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31426440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix Metalloproteinase-Targeted Imaging of Lung Inflammation and Remodeling.
    Golestani R; Razavian M; Ye Y; Zhang J; Jung JJ; Toczek J; Gona K; Kim HY; Elias JA; Lee CG; Homer RJ; Sadeghi MM
    J Nucl Med; 2017 Jan; 58(1):138-143. PubMed ID: 27469361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of Novel Nuclear Medical Imaging Probes for Quantification of Matrix Metalloproteinases in Diseases].
    Kondo N
    Yakugaku Zasshi; 2020; 140(1):7-13. PubMed ID: 31902888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel strategy to tag matrix metalloproteinases-positive cells for in vivo imaging of invasive and metastatic activity of tumor cells.
    Zhao T; Harada H; Teramura Y; Tanaka S; Itasaka S; Morinibu A; Shinomiya K; Zhu Y; Hanaoka H; Iwata H; Saji H; Hiraoka M
    J Control Release; 2010 May; 144(1):109-14. PubMed ID: 20096316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofluorinated pyrimidine-2,4,6-triones as molecular probes for noninvasive MMP-targeted imaging.
    Breyholz HJ; Wagner S; Faust A; Riemann B; Höltke C; Hermann S; Schober O; Schäfers M; Kopka K
    ChemMedChem; 2010 May; 5(5):777-89. PubMed ID: 20373323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo biodistribution of radiolabeled MMP-2/9 activatable cell-penetrating peptide probes in tumor-bearing mice.
    van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
    Contrast Media Mol Imaging; 2015; 10(1):59-66. PubMed ID: 24823643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design of matrix metalloproteinase-13 activatable probes for enhanced specificity.
    Zhu L; Ma Y; Kiesewetter DO; Wang Y; Lang L; Lee S; Niu G; Chen X
    ACS Chem Biol; 2014 Feb; 9(2):510-6. PubMed ID: 24266806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability.
    Müller A; Krämer SD; Meletta R; Beck K; Selivanova SV; Rancic Z; Kaufmann PA; Vos B; Meding J; Stellfeld T; Heinrich TK; Bauser M; Hütter J; Dinkelborg LM; Schibli R; Ametamey SM
    Nucl Med Biol; 2014 Aug; 41(7):562-9. PubMed ID: 24853402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probes for non-invasive matrix metalloproteinase-targeted imaging with PET and SPECT.
    Matusiak N; van Waarde A; Bischoff R; Oltenfreiter R; van de Wiele C; Dierckx RA; Elsinga PH
    Curr Pharm Des; 2013; 19(25):4647-72. PubMed ID: 23339739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioactive smart probe for potential corrected matrix metalloproteinase imaging.
    Huang CW; Li Z; Conti PS
    Bioconjug Chem; 2012 Nov; 23(11):2159-67. PubMed ID: 23025637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging matrix metalloproteinase expression in tumors.
    Li WP; Anderson CJ
    Q J Nucl Med; 2003 Sep; 47(3):201-8. PubMed ID: 12897711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of a new fluorescence-labeled MMP inhibitor to image tumor MMP activity in vivo in comparison to an MMP-activatable probe.
    Waschkau B; Faust A; Schäfers M; Bremer C
    Contrast Media Mol Imaging; 2013; 8(1):1-11. PubMed ID: 23109387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of matrix metalloproteinase fluorogenic probes for osteoarthritis imaging.
    Ryu JH; Lee A; Na JH; Lee S; Ahn HJ; Park JW; Ahn CH; Kim BS; Kwon IC; Choi K; Youn I; Kim K
    Amino Acids; 2011 Nov; 41(5):1113-22. PubMed ID: 20953646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in Vitro and in Vivo Evaluation of MMP-12 Selective Optical Probes.
    Bordenave T; Helle M; Beau F; Georgiadis D; Tepshi L; Bernes M; Ye Y; Levenez L; Poquet E; Nozach H; Razavian M; Toczek J; Stura EA; Dive V; Sadeghi MM; Devel L
    Bioconjug Chem; 2016 Oct; 27(10):2407-2417. PubMed ID: 27564088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design strategy for a near-infrared fluorescence probe for matrix metalloproteinase utilizing highly cell permeable boron dipyrromethene.
    Myochin T; Hanaoka K; Komatsu T; Terai T; Nagano T
    J Am Chem Soc; 2012 Aug; 134(33):13730-7. PubMed ID: 22830429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Gd(III)-based probes for MR molecular imaging of matrix metalloproteinases.
    Gringeri CV; Menchise V; Rizzitelli S; Cittadino E; Catanzaro V; Dati G; Chaabane L; Digilio G; Aime S
    Contrast Media Mol Imaging; 2012; 7(2):175-84. PubMed ID: 22434630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species.
    Roy R; Louis G; Loughlin KR; Wiederschain D; Kilroy SM; Lamb CC; Zurakowski D; Moses MA
    Clin Cancer Res; 2008 Oct; 14(20):6610-7. PubMed ID: 18927302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.